News Image

Palisade Bio Strengthens Clinical Leadership Team with Appointment of James Izanec, MD, AGAF as Vice President, Clinical Development

Provided By GlobeNewswire

Last update: Dec 2, 2025

Veteran gastroenterologist and clinical development leader with deep expertise driving global Phase 2/3 programs across immunology, neurology, and gastrointestinal disease

Read more at globenewswire.com

PALISADE BIO INC

NASDAQ:PALI (12/23/2025, 8:27:55 PM)

After market: 2.09 0 (0%)

2.09

+0.01 (+0.48%)



Find more stocks in the Stock Screener

Follow ChartMill for more